| Beneficial Effects of L- and N-type Calcium Channel Blocker on Glucose and Lipid Metabolism and Renal Function in Patients with Hypertension and Type II Diabetes Mellitus. | |
| | |
MedLine Citation:
|
PMID: 20337636 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
It has been proved that cilnidipine has N-type calcium channels inhibitory activity as well as L-type calcium channels and inhibits excessive release of norepinephrine from the sympathetic nerve ending. This study was undertaken to compare the efficacy of amlodipine (an inhibitor of L-type calcium channels) and cilnidipine (an inhibitor of both L-type and N-type calcium channels) in patients with hypertension and type II diabetes mellitus. Seventy-seven hypertensive patients were divided into two groups according to presence/absence of type II diabetes mellitus. In these two groups of patients, the effects of amlodipine and cilnidipine on glucose and lipid metabolism and renal function were compared. As for glucose and lipid metabolism, homeostasis model assessment insulin resistance (HOMA-R) level in the non-diabetic group and triglyceride in the diabetes group were significantly lower with cilnidipine than with amlodipine. As regards renal function in the diabetic group, estimated glomerular filtration rate (eGFR) was significantly higher and urinary albumin/creatinine ratio was significantly lower with cilnidipine than with amlodipine. Cilnidipine which inhibits N-type calcium channels is more useful for patients with hypertension and diabetes mellitus from its effects on glucose and lipid metabolism and renal function. |
| | |
Authors:
|
Takashi Masuda; Misao N Ogura; Tatsumi Moriya; Naonobu Takahira; Takuya Matsumoto; Toshiki Kutsuna; Miyako Hara; Naoko Aiba; Chiharu Noda; Tohru Izumi |
Related Documents
:
|
7558466 - Increased sympathetic nervous system activity in chinese hypertensive patients with typ... 18520136 - expression and regulation of renal sodium-cotransporters and -antiporters, and related-... 19800706 - Effect of treatment with losartan on salt sensitivity and sglt2 expression in hypertens... 1499466 - Impact of associated conditions on glycemic control of niddm patients. 8749676 - Medical management of nephropathy in type i diabetes mellitus: current recommendations. 21289226 - Daily consumption of vitamin d- or vitamin d + calcium-fortified yogurt drink improved ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cardiovascular therapeutics Volume: 29 ISSN: 1755-5922 ISO Abbreviation: Cardiovasc Ther Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101319630 Medline TA: Cardiovasc Ther Country: England |
Other Details:
|
Languages: eng Pagination: 46-53 Citation Subset: IM |
Copyright Information:
|
© 2010 Blackwell Publishing Ltd. |
Affiliation:
|
Department of Rehabilitation, Kitasato University School of Allied Health Sciences, Kanagawa, Japan Department of Angiology and Cardiology, Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine, Kanagawa, Japan Department of Cardio-angiology, Kitasato University School of Medicine, Kanagawa, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Long-Term Survival of Routine Implantable Cardioverter/Defibrillator Recipients Appears to be Signif...
Next Document: Paradoxical Decrease in High-Density Lipoprotein Cholesterol with Fenofibrate: A Quite Rare Phenomen...